NSC 185058
NSC 185058 is a small molecule inhibitor that selectively targets the ATG4B cysteine protease, a key regulator of autophagy. By inhibiting ATG4B, it effectively attenuates autophagic flux and serves as a valuable research tool for studying autophagy in both cellular and animal models of cancer and neurodegenerative diseases.
Product Specifications
CAS Number
39122-38-8
Product Name Alternative
CysteineProtease, Cysteine Protease, Autophagy-related 4, Autophagy, ATG4B, Atg4, Cathepsin, NSC 185058, NSC185058, NSC-185058, Inhibitor, inhibit
Field of Research
Cell Biology, Neuroscience, Protein Biochemistry
Purity
99.27% (May vary between batches)
Solubility
Ethanol:2.5 mg/mL (11.61 mM) ; DMSO:30 mg/mL (139.36 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (9.29 mM)
Smiles
S=C (Nc1ccccn1) c1ccccn1
Molecular Formula
C11H9N3S
Molecular Weight
215.27
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Monoclonal Antibody to Complement Component 5a (C5a)
Monoclonal Antibody to Complement Component 5a (C5a)
Monoclonal Antibody to Complement Component 5a (C5a)
Monoclonal Antibody to Complement Component 5a (C5a)
ErbB2 (Receptor Tyrosine-protein Kinase erbB-2, Metastatic Lymph Node Gene 19 Protein, MLN 19, Proto-oncogene Neu, Proto-oncogene c-ErbB-2, Tyrosine Kinase-type Cell Surface Receptor HER2, CD340, p185erbB2, HER2, MLN19, NEU, NGL) (MaxLight 750) discontinued
